Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytoma, Malignant Fibrous × itacitinib × 1 year × Clear all

Sponsor

Conditions

Myeloproliferative Disorders 4 Primary Myelofibrosis 2 Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Thrombocytosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Inhibition, Psychological 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Graft vs Host Disease 1 Carcinoma, Non-Small-Cell Lung 1 B-cell Malignancies 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

pembrolizumab 4 Specimen Handling 3 Doxorubicin 3 Radiotherapy 2 Radiation 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 Biopsy 2 tremelimumab 1 talimogene laherparepvec 1 regorafenib 1 pazopanib 1 olaratumab 1 futibatinib 1 fludarabine 1 eribulin 1 durvalumab 1 cabozantinib 1 avelumab 1 aldesleukin 1 X-Rays 1 Trabectedin 1 Standard of Care 1 Quality of Life 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Histamine H2 Antagonists 1 Famotidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡